Clinical Trial Update: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial evaluating the efficacy and safety of Highly Purified Urofollitropin for ovulation induction in Chinese women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation

Drugs mentioned

• Highly Purified Urofollitropin (urofollitropin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Anovulation | Phase 3 | Status: COMPLETED